Home » Topics » BioWorld Science

BioWorld Science
RSS

Shanghai Newsky Biotechnology identifies PLA2G7 inhibitors

Jan. 25, 2022

Medshine Discovery synthesizes new ER-alpha degradation inducers

Jan. 25, 2022

Wuhan LL Science and Technology Development divulges TRPC5 antagonists

Jan. 25, 2022

Chinese researchers patent new antibacterial compounds

Jan. 25, 2022

Suzhou Vintagence Pharma discloses new GTPase KRAS mutant inhibitors

Jan. 25, 2022

CAR plus a CD38-directed chimeric costimulatory receptor enhances tumor killing

Jan. 25, 2022

YAP1/TAZ signaling plays a role in colorectal cancer

Jan. 25, 2022

Juva Life advances JUVA-041 into preclinical development

Jan. 24, 2022

Small molecule improves AD neuropathology in mice

Jan. 24, 2022

TACH-101 shows activity in gastric and colorectal cancer models

Jan. 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...